Združene države Amerike - angleščina - NLM (National Library of Medicine)

key therapeutics, llc - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen 125 mg in 5 ml - carefully consider the potential benefits and risks of naproxen suspension and other treatment options before deciding to use naproxen suspension. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings; gastrointestinal bleeding, ulceration, and perforation) . naproxen suspension is indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile rheumatoid arthritis naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient's weight. naproxen suspension is also indicated: - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout -

Irska - angleščina - HPRA (Health Products Regulatory Authority)

ltt pharma limited - paroxetine hydrochloride - oral suspension - 20 mg/ml

Irska - angleščina - HPRA (Health Products Regulatory Authority)

ltt pharma limited - paroxetine hydrochloride - oral suspension - 20 mg/ml

Velika Britanija - angleščina - VMD (Veterinary Medicines Directorate)

eu pharmaceuticals ltd - ivermectin, triclabendazole - oral suspension - endectocide - sheep

Velika Britanija - angleščina - VMD (Veterinary Medicines Directorate)

huvepharma n.v. - meloxicam - oral suspension - anti inflammatory nsaid - pigs

Združene države Amerike - angleščina - NLM (National Library of Medicine)

nivagen pharmaceuticals, inc. - nystatin (unii: bdf1o1c72e) (nystatin - unii:bdf1o1c72e) - nystatin oral suspension is indicated for the treatment of candidiasis in the oral cavity. the preparation is contraindicated in patients with a history of hypersensitivity to any of its components.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

bryant ranch prepack - nystatin (unii: bdf1o1c72e) (nystatin - unii:bdf1o1c72e) - nystatin oral suspension is indicated for the treatment of candidiasis in the oral cavity. the preparation is contraindicated in patients with a history of hypersensitivity to any of its components.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

bryant ranch prepack - nystatin (unii: bdf1o1c72e) (nystatin - unii:bdf1o1c72e) - nystatin oral suspension is indicated for the treatment of candidiasis in the oral cavity. the preparation is contraindicated in patients with a history of hypersensitivity to any of its components.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

bryant ranch prepack - nystatin (unii: bdf1o1c72e) (nystatin - unii:bdf1o1c72e) - nystatin oral suspension is indicated for the treatment of candidiasis in the oral cavity. the preparation is contraindicated in patients with a history of hypersensitivity to any of its components.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

remedyrepack inc. - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim oral suspension, usp and other antibacterial drugs, sulfamethoxazole and trimethoprim oral suspension, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. urinary tract infections for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris. it is recommended that initial episodes of uncomplicated urinary trac